Igc completes cohort 2 of its phase 1 thc-based clinical trial on alzheimer's patients

Potomac, md.--(business wire)-- #ad--igc completes cohort 2 of its phase 1 tetrahydrocannabinol (“thc”)-based investigational new drug clinical trial on alzheimer's patients.

IGC Ratings Summary

IGC Quant Ranking